Dabigatran and vitamin K antagonists' use in naïve patients with non-valvular atrial fibrillation: a cross-sectional study of primary care-based electronic health records.
Bogdan VlachoMaria Giner-SorianoEdurne Zabaleta-Del-OlmoAlbert Roso-LlorachAna García-SangenísRosa Morros-PedrósPublished in: European journal of clinical pharmacology (2017)
Most patients recently diagnosed with non-valvular atrial fibrillation initiated treatment with VKA. Primary healthcare patients with non-valvular atrial fibrillation initiating dabigatran are younger, had a lower risk of stroke or bleeding, fewer comorbidity and more history of stroke and intracranial haemorrhage compared to those who were initiated on VKA.
Keyphrases
- atrial fibrillation
- oral anticoagulants
- electronic health record
- catheter ablation
- left atrial
- primary care
- left atrial appendage
- direct oral anticoagulants
- healthcare
- heart failure
- end stage renal disease
- percutaneous coronary intervention
- newly diagnosed
- prognostic factors
- physical activity
- risk factors
- left ventricular
- patient reported outcomes
- health information
- acute coronary syndrome
- subarachnoid hemorrhage
- venous thromboembolism
- aortic valve